Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
5,214,607
-
Share change
-
+5,214,607
-
Total reported value
-
$57,723,000
-
Price per share
-
$11.08
-
Number of holders
-
9
-
Value change
-
+$57,723,140
-
Number of buys
-
9
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q3 2017
As of 30 Sep 2017,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,214,607 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, 683 Capital Management, LLC, ACUTA CAPITAL PARTNERS, LLC, venBio Select Advisor LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, UNITED SERVICES AUTOMOBILE ASSOCIATION, Hartford Financial Management Inc., Tower Research Capital LLC (TRC), UBS Group AG, and Federation des caisses Desjardins du Quebec.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.